Latest GlaxoSmithKline Stories
LifeScienceIndustryResearch.com adds Latest Report on "Global and Chinese Vardenafil (CAS 224785-90-4) Industry, 2009-2019 Market Research Report" to its store. DALLAS, July 27, 2014
DUBLIN, July 25, 2014 /PRNewswire/ -- Research and Markets has announced the
No. 1 Prescribed Allergy Treatment Ingredient(1) to be Available OTC PARSIPPANY, N.J., July 24, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S.
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
LONDON, July 23, 2014 /PRNewswire/ -- Global healthcare company GSK reports Q2 results reflecting a business that is facing currency headwinds, increased price competition
District Court Judge Orders Apotex to Immediately Recall the Authorized Generic from its Direct Customers and to Stop Selling and Supplying the Product PITTSBURGH, July 23, 2014 /PRNewswire/
PITTSBURGH, July 17, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S.
Matters Involving Ongoing Litigation to Be Discussed DALLAS (PRWEB) July 08, 2014 Parties involved in lawsuits regarding the anti-psychotic drug Risperdal
CARLSBAD, Calif., July 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs.
- An armed gangster.